Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Blue Note Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Blue Note Therapeutics

Blue Note Therapeutics

Series A

Blue Note Therapeutics: Digital prescriptions via mobile, merging scientific expertise and patient advocacy.

HQ
San Francisco, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees

Blue Note Therapeutics is a prescription digital therapeutics company founded in 2018 and based in San Francisco, California. The company merges deep scientific and clinical expertise to offer digital prescriptions via mobile devices. It collaborates with medical researchers and patient advocacy organizations to provide accessible therapeutic solutions to patients.

Blue Note Therapeutics has made significant strides in the digital health sector, leveraging technology to improve patient outcomes. The company's innovative approach has garnered attention and support from the medical community, enhancing its impact on patient care.

Blue Note Therapeutics - Similar Companies

Notable Health logo

Notable Health

notablehealth.com

NovaXS Biotech logo

NovaXS Biotech

novaxs.co

Lana Health logo

Lana Health

lana.health

Digital Medical Tech logo

Digital Medical Tech

Bluejay Therapeutics logo

Bluejay Therapeutics

bluejaytx.com

Chorus Health logo

Chorus Health

chorushealth.io

Wave Therapeutics logo

Wave Therapeutics

Rezilient Health logo

Rezilient Health

Ella logo

Ella

Nicolette logo

Nicolette

nicolette.com

CardioCube logo

CardioCube

Duality Health logo

Duality Health

duality.health

Seremedi logo

Seremedi

seremedi.com

Star Therapeutics logo

Star Therapeutics

Swing Therapeutics logo

Swing Therapeutics

Blue Note Therapeutics - Quick Facts

Who are Blue Note Therapeutics' competitors?

Companies similar to Blue Note Therapeutics include Notable Health, NovaXS Biotech, Lana Health and Digital Medical Tech.

When was Blue Note Therapeutics founded?

Blue Note Therapeutics was founded in 2018.

Where is Blue Note Therapeutics' headquarters located?

Blue Note Therapeutics' headquarters is located in San Francisco, CA, US.

When was Blue Note Therapeutics' last funding round?

Blue Note Therapeutics' most recent funding round was for $5.2M (USD) in September 2021.

How much has Blue Note Therapeutics raised to-date?

As of Sep 9, 2021, Blue Note Therapeutics has raised a total of $46.9M (USD).

How many employees does Blue Note Therapeutics have?

Blue Note Therapeutics has 46 employees as of Feb 5, 2024.

Blue Note Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Mobile
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Digital Therapeutics
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies